a public good project by the
Synthesis
Company
of California

© 2026

James Smith | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

James Smith

Neovacs (France)(FR)

Research Areas

SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery, Animal Virus Infections Studies

Most-Cited Works

→ Safety, Tolerability, and Immunogenicity of NeomiVac, a Next-Generation mRNA–Lipid Nanoparticle Vaccine Comprising a Novel Ionisable Lipid: A First-In-Human, Phase 1, Dose-Escalation Trial(2026)